Français

Contact Listing Owner






Your message has been sent!

Email All Listing Owners

Please fill in this form to send a message to all listing owners in your contact list.






Your message has been sent!

Email My List To Me

Please fill in the following form to receive a copy of your contact list via email.




Your message has been sent!

Print My List

  • Your list is empty. You must add listings to your list before you can send an email.

Categories

Dentistry(15)
Medicine(666)
Nursing(52)
Pharmaceutical Sciences(29)
Public & Population Health(61)
Rehabilitation Sciences(36)
Social Science & Humanities(60)
Uncategorized(2)
Veterinary Medicine(28)

States/Provinces

Alberta(112)
Arizona(2)
British Columbia(121)
California(2)
DC(1)
Florida(1)
Manitoba(26)
New Jersey(1)
New York(1)
Newfoundland(7)
Nova Scotia(24)
Ontario(307)
Prince Edward Island(3)
Québec(181)
Saskatchewan(28)
Utah(1)

Alphabetical Search

Categorical Search

Full Search

Interim Dean, University of Toronto

Professor Allen, currently serving as Interim Dean of the Leslie Dan Faculty of Pharmacy, University of Toronto, leads a highly productive research program developing advanced drug formulations. Her research has yielded >130 publications with several featured in journal covers and editorials. Dr. Allen is committed to the commercialization of her research, with a number of innovations moving towards clinical development. She has played a significant leadership role at her University, at granting agencies and in scientific societies. A dedicated member of the Controlled Release Society, she ...

My research interests focus on the personal and professional development of the health human resources workforce. As the complexity and interdependency of care provision advances, the importance of investing in continuous professional development of health professionals increases. My research recognizes that artificial divisions between "personal" and "professional" development are counterproductive to the goal of enhanced quality care. Failure to recognize these important development needs in the workforce leads to burnout, disengagement, and ultimately error. A particular focus of my ...

Distinguished University Professor, Western University

Dr. John R. Bend is a Distinguished University Professor at The University of Western Ontario. He is internationally known for his research on molecular and environmental toxicology. His research focuses on the metabolic activation and detoxication of xenobiotic chemicals, and of the importance of this concept in environmental toxicology. He is also known for his expertise on the toxicity of chemicals used in industry, and of the safety assessment of chemicals that occur as food additives and contaminants, including pesticides. He is a member of the Council of Canadian Academies Expert Panel ...

Professor, Leslie Dan Faculty of Pharmacy, University of Toronto

Dr. Reina Bendayan is a Professor, Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, and Career Scientist, Ontario HIV Treatment Network. Her research explores membrane drug transport particularly in HIV infection. A Fellow of the American and Canadian Associations for Pharmaceutical Sciences, Dr. Bendayan is the recipient of international and national research and leadership awards. She serves on the Boards of international and national scientific associations, and is Chair, Scientific Officer and Expert Reviewer on national and international ...

Dr Bérard has training from McGill University, and Harvard Medical School. She is full professor of perinatal epidemiology at the University of Montreal, Faculty of Pharmacy, and CHU Ste-Justine; and adjunct professor at the Faculty of Medicine, Université Claude Bernard, Lyon, France. Dr Bérard holds a Canada Research Chair Tier 1 on Medications and Pregnancy; is a Fellow of the International Society of Pharmacoepidemiology, and a Birth Defects Society voting member. Dr Bérard has published over 500 scientific papers/abstracts; and recently received a Most Distinguished Scientist Award from ...

Vice-Provost Faculty and Academic Life, University of Toronto

Professor Heather Boon, Vice-Provost Faculty and Academic Life at the University of Toronto, is internationally known for her research into the safety, efficacy and regulation of complementary and traditional medicine, especially natural health products. She founded the Canadian Interdisciplinary Network for Complementary and Alternative Medicine Research in 2004 and served as President of the International Society for Complementary Medicine Research from 2013-14. From 2014-2018 she was the Dean of the Leslie Dan Faculty of Pharmacy, University of Toronto. She currently advises Health Canada ...

Distinguished University Professor, McMaster University

Dr. Eric Brown is a Distinguished University Professor in the Department of Biochemistry and Biomedical Sciences at McMaster University. He is a Fellow of the American Academy of Microbiology and has received a number of awards including a Killam Research Fellowship and Canadian Society of Microbiologists Murray Award. Brown is a former Chair of his department and founding Director of McMaster’s Biomedical Discovery and Commercialization program. He has served on a variety of advisory boards, including a term as President of the Canadian Society of Molecular Biosciences. His research aims to ...

Retired, University of British Columbia

Helen Burt holds the Angiotech Professorship in Drug Delivery and is Associate Dean for Research and Graduate Studies in the Faculty of Pharmaceutical Sciences at UBC. Her research interests are novel controlled release delivery systems for drugs and the mechanisms of crystal induced inflammatory arthritis. Her work is supported by grants from CIHR and other sources and she has supervised over 30 research trainees. She recently completed a 3 year term as the CIHR and Michael Smith Foundation for Health Research Coordinator in the VP Research Office at UBC and worked with a team to create new ...

Sylvain Chemtob is a neonatologist and pharmacologist, and professor of Pediatrics, with joint appointments in Pharmacology and Ophthalmology at Université de Montréal. His research is focused on reactive oxygen species and lipid mediators in ischemic neuropathies (eg. retinopathy of prematurity, stroke) with emphasis on the developing subject. He pioneered the concept of functional nuclear G protein-coupled receptors. He has also developed two powerful rationale drug design platform technologies enabling the rapid generation of antagonists to cell surface proteins (receptors, channels, etc); ...

Professor and Former Dean, University of British Columbia

Professor of Pharmacy and Pharmaceutical Sciences, University of Alberta

Dr. Neal Davies is an outstanding researcher, administrator, teacher, pharmacist and pharmaceutical scientist. He is an international renowned in drug investigations from discovery to patient recovery. His research has yielded > 500 publications. He is also a dedicated administrator having been Dean of two U15 Pharmacy Faculties at the Universities of Manitoba and Alberta. Dr. Davies was the founder of Applied Pharmaceutical Innovation (API) which lead to the successful establishment of the Canadian Critical Drug Initiative. (CCDI). He has distinguished performance in the academic health ...

Professor, University of Waterloo

David Edwards is Professor at the University of Waterloo where he served as Hallman Director of the School of Pharmacy from 2011-2020. He is also Professor Emeritus at Wayne State University. He is a highly cited researcher in pharmacokinetics and drug interactions. He has served in a number of leadership roles including President of the Association of Faculties of Pharmacy of Canada (AFPC) and the Canadian Council for the Accreditation of Pharmacy Programs. He is a Fellow of the American College of Clinical Pharmacy, received the Honorary Life Award from the Canadian Pharmacists Association ...

Professor and Director, Doctor of Pharmacy Program, Faculty, University of British Columbia

Mary Ensom (formerly Chandler) is a leading authority on clinical pharmacokinetics and pharmacodynamics. Her sustained research program and prolific high-quality publications have greatly enhanced our knowledge of the impact of disease, age, hormonal influences, genetics, and other factors on drug action and disposition. As an integrator who bridges the gap between the basic and clinical sciences, she learns about patient problems as a clinician, researches those questions, and passes along the learning to her students. Dr. Ensom is also well recognized for her teaching and administrative ...

Dr Jean-Pierre Grégoire’s work has changed competencies and roles of pharmacists as health professionals. He pioneered the teaching of pharmacoepidemiology in a faculty of pharmacy. As Dean of Pharmacy at Laval University, he led the creation of a competency-based entry-level PharmD program innovative in both design and instructional methods. As a researcher, he contributed to better characterize adherence to drug treatments. As president of the Quebec Order of Pharmacists, he led a change in pharmacy legislation that requires Quebec pharmacies to have a private section for counselling, and ...

Professeure titulaire, Faculté de pharmacie, Université Laval

Professor at Université Laval, Canada Research Chair in Pharmacogenomics and cdirector of the Cancer Research Center, Dr. Chantal Guillemette is a world leader in the field of drug and steroid metabolism and cancer pharmacogenomics with impressive research accomplishments. She has contributed to high-quality and clinically impactful research by leading an innovative program in close partnership with clinicians and with an exemplary record of training and mentoring successful research trainees. Her work has provided a deeper understanding of the molecular basis of variable therapeutic drug ...

Dr. Hindmarsh was appointed Executive Director of the Canadian Council for Accreditation of Pharmacy Programs in 2010.  He is also currently Dean Emeritus of the Leslie Dan Faculty of Pharmacy at the University of Toronto where he served as Dean for 11 years. Previously he was also Dean at the U of Manitoba. His research expertise is in the area of drug distribution and forensic toxicology.  He is the author of two books and 80+ scientific articles.

Neena B. Schwartz Professor of Chemistry and Biomed Eng, Northwestern University

An internationally recognized scientist who has made numerous contributions related to the development of new clinical diagnostic technologies. Her research group uses an interdisciplinary approach to develop new seniors for biomarkers of disease and applies them to make the diagnosis of infectious disease and cancer faster and more accurate. She has published over 130 scientific articles that have been cited more than 6,000 times, invented 20+ patents and co-founded two clinical diagnostic companies.  

Professor & Chair, Division of Clinical Pharmacology, Western University

Professor, University of Western Ontario Dr. Richard Kim, Professor of Medicine at the University of Western Ontario, is an acknowledged leader in the field of pharmacogenomics and the application of pharmacogenomics technologies to the delivery personalized medicine-based care to our patients.Dr. Kim holds the Wolfe Medical Research Chair in Pharmacogenomics at Western. He was the first in Canada to start a personalized medicine clinic, focused on drugs such as warfarin, statin class of lipid lowering drugs, and the breast cancer drug tamoxifen. He is also applying personalized medicine ...

Professor, University of British Columbia

Dr. Muhammad Mamdani's research examines the effectiveness and safety of drug therapies to inform drug policy as well as the integration of advanced analytics into clinical practice. He has published over 400 studies in leading medical journals and his work has been cited over 15,000 times.

Dr. McMaster is the Scientific Director of the Canadian Institutes of Health Research (CIHR) Institute of Genetics and Professor of Pharmacology at Dalhousie University in Halifax, Canada, Previously, Dr. McMaster was the Carnegie and Rockefeller Professor and Head of the Department of Pharmacology, co-Director of the Cheminformatics Drug Discovery Lab, and Assistant Dean for Graduate and Post-doctoral Studies in the Faculty of Medicine at Dalhousie University. His research encompasses several genetic models ranging from yeast to zebrafish to mice with the aim of finding therapies for ...

Professor & Former Dean, Faculty of Pharmaceutical Sciences, University of British Columbia

Dr. Sindelar was appointed Dean of the Faculty of Pharmaceutical Sciences at UBC in 2002. This followed 19 years at the University of Mississippi where, for the last nine years of his tenure, he held the position of Professor and Chair of Medicinal Chemistry, School of Pharmacy. Dr. Sindelar is Dean of the Faculty of Pharmaceutical Sciences, UBC Dr. His expertise lies in medicinal chemistry, computer-aided drug discovery and design, and pharmaceutical biotechnology. He has published 45 refereed journal articles, 6 U.S. patents, several foreign patents. He serves as a member of the editorial ...

Professor and Associate Director; Research, Dalhousie University

Ingrid Sketris is a Professor of Pharmacy at Dalhousie University. She was President of the Association of Faculties of Pharmacy of Canada and is a fellow of the Canadian Society of Hospital Pharmacists and the American College of Clinical Pharmacy. She is one of 12 chairs funded by CHSRF/CIHR as part of the Capacity for Applied Developmental Research and Evaluation in Health Services program. Her research involves examining approaches to increase the uptake of evidence-based drug therapies and the effectiveness of policy levers used by pharmacare programs to provide effective and affordable ...

Professor, McGill University

Szyf received his Ph. D from the Hebrew University and did his postdoctoral fellowship in Genetics at Harvard Medical School, joined the department in 1989 and currently holds a James McGill Professorship and GlaxoSmithKline-CIHR Chair in Pharmacology. He is the founding co-director of the Sackler Institute for Epigenetics and Psychobiology at McGill and is a Fellow of the Canadian Institute for Advanced Research Experience-based Brain and Biological Development program. Szyf has been the founder of the first "Pharma" to develop epigenetic pharmacology "Methylgene Inc." and the first journal ...

Professor, University of Toronto

Dr. Anna Taddio, Professor, Leslie Dan Faculty of Pharmacy, and Senior Associate Scientist, The Hospital for Sick Children, is internationally recognized for her work related to pain management during medical procedures and the long-term harms of unmitigated pain. Dr. Taddio founded and currently leads a national inter-disciplinary, multi-sectoral team, Help Eliminate Pain in Kids and Adults (HELPinKids&Adults), investigating and promoting evidence-based pain management during vaccination. The World Health Organization adopted the recommendations from Dr. Taddio and her team in its first ...

GalenusRx Inc

Since spring 2007, Dr. Jacques Turgeon has been appointed Director of Research at the Centre hospitalier de l’Université de Montréal. From 2005-2007 he was Vice-Rector — Research, Université de Montréal after having served as Dean of the Faculté de Pharmacie there. Dr. Turgeon’s research interests have always been directed towards the study of factors responsible for inter-subject variability in drug response and specifically in the role of pharmacogenetics in cardiovascular drug actions. Dr. Turgeon has integrated in vitro (patch-clamp technique, in vitro metabolism and molecular biology) ...

Professor, Faculty of Medicine, Faculty of Pharmacy, University of Toronto

Jack Uetrecht is Professor in the Faculty of Pharmacy at the University of Toronto. His research has focused on the mechanism of idiosyncratic drug reactions with combined approaches involving organic chemistry, drug metabolism, reactive metabolites, immunology, molecular biology and clinical aspects. He holds a CRC chair in Adverse Drug Reactions and is internationally recognized as a leader in this field. He initiated the first Gordon Research Conference on Adverse Drug Reactions and was its first chair. He has chaired many committees including the Scientific Advisory Panel on ...

Distinguished University Scholar & Adjunct Professor, University of British Columbia

Dr. Wasan was appointed Dean of the College of Pharmacy and Nutrition in August 2014. He has published over 520 peer-reviewed articles and abstracts in the area of lipid-based drug delivery and lipoprotein-drug interactions. Dr. Wasan completed his undergraduate degree in Pharmacy at the University of Texas at Austin and his Ph.D. at the University of Texas Medical Center in Houston Texas at MD Anderson Cancer Center in Cellular and Molecular Pharmacology. After completing a postdoctoral fellowship in Cell Biology at the Cleveland Clinic, Dr. Wasan joined the Faculty of Pharmaceutical ...

Professor and Senior Associate Dean (Research), University of Calgary

Gerald Zamponi is one of the world’s leading researchers on the molecular neurophysiology of ion channels. His seminal research has resulted in numerous contributions to both the basic and biomedical fields. He has described the underlying mechanisms of calcium channel inactivation, permeation and modulation by a variety of intracellular signaling molecules and pathways. His work has also defined the physiological consequences of genetic defects associated with calcium channel dysfunction in generalized epilepsies and congenital night blindness. The work has also defined novel molecular ...